Literature DB >> 8949657

Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.

P Ljubuncic1, B Fuhrman, J Oiknine, M Aviram, A Bomzon.   

Abstract

BACKGROUND: Kupffer cells are essential for normal hepatic homeostasis and when stimulated, they secrete reactive oxygen species, nitric oxide, eicosanoids, and cytokines. Some of these products are cytotoxic and attack nucleic acids, thiol proteins, or membrane lipids causing lipid peroxidation. Hydrophobic bile acids, such as deoxycholic acid (DCA), can damage hepatocytes by solubilising membranes and impairing mitochondrial function, as well as increasing the generation of reactive oxygen species.
OBJECTIVES: The hypothesis that hydrophobic bile acids could stimulate Kupffer cells to increase their capacity to generate reactive oxygen species by measuring cellular lipid peroxidation was tested. Because the hydrophilic bile acid, ursodeoxycholic acid (UDCA) can block hydrophobic bile acid induced cellular phenomena, it was also hypothesised that UDCA could antagonise macrophage activation by hydrophobic bile acids to blunt their capacity to generate reactive oxygen species.
METHODS: J-774A.1 murine macrophages were incubated for 24 hours with either 10(-5) M and 10(-4) M (final concentration) DCA alone, or 10(-4) M UDCA alone, or a mixture of 10(-4) M 1:1 molar ratio of DCA and UDCA. At the end of the incubation period, the culture medium was collected for determination of cellular lipid peroxidation by measuring the malondialdehyde (MDA) content in the medium with the thiobarbituric acid reactive substances assay.
RESULTS: 10(-5) M and 10(-4) M DCA increased MDA generation by cultured macrophages. 10(-4) M UDCA alone did not increase MDA generation but blocked the peroxidative actions of DCA.
CONCLUSIONS: Hydrophobic bile acids, after their hepatic retention, can oxidatively activate Kupffer cells to generate reactive oxygen species. Because UDCA can block this action, the beneficial effect of UDCA is, in part, related to its ability to act as an antioxidant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949657      PMCID: PMC1383359          DOI: 10.1136/gut.39.3.475

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Malondialdehyde determination as index of lipid peroxidation.

Authors:  H H Draper; M Hadley
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Mechanism of bile acid-induced HCO3-(-)rich hypercholeresis. An analysis based on quantitative acid-base chemistry.

Authors:  M S Anwer
Journal:  J Hepatol       Date:  1992-01       Impact factor: 25.083

3.  A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.

Authors:  H Oka; G Toda; Y Ikeda; N Hashimoto; Y Hasumura; T Kamimura; Y Ohta; T Tsuji; N Hattori; T Namihisa
Journal:  Gastroenterol Jpn       Date:  1990-12

4.  Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.

Authors:  A Stiehl; G Rudolph; R Raedsch; B Möller; U Hopf; E Lotterer; J Bircher; U Fölsch; J Klaus; R Endele
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

5.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.

Authors:  R E Poupon; B Balkau; E Eschwège; R Poupon
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

6.  Immunomodulatory effects of ursodeoxycholic acid on immune responses.

Authors:  M Yoshikawa; T Tsujii; K Matsumura; J Yamao; Y Matsumura; R Kubo; H Fukui; S Ishizaka
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

7.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.

Authors:  A Crosignani; M Podda; P M Battezzati; E Bertolini; M Zuin; D Watson; K D Setchell
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

9.  Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

Authors:  D M Heuman; A S Mills; J McCall; P B Hylemon; W M Pandak; Z R Vlahcevic
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.

Authors:  D Gurantz; C D Schteingart; L R Hagey; J H Steinbach; T Grotmol; A F Hofmann
Journal:  Hepatology       Date:  1991-03       Impact factor: 17.425

View more
  26 in total

1.  Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.

Authors:  M Leuschner; C F Dietrich; T You; C Seidl; J Raedle; G Herrmann; H Ackermann; U Leuschner
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

3.  Galectin-3 regulates inflammasome activation in cholestatic liver injury.

Authors:  Jijing Tian; Guoxiang Yang; Huan-Yuan Chen; Daniel K Hsu; Alexey Tomilov; Kristin A Olson; Ali Dehnad; Sarah R Fish; Gino Cortopassi; Bin Zhao; Fu-Tong Liu; M Eric Gershwin; Natalie J Török; Joy X Jiang
Journal:  FASEB J       Date:  2016-09-14       Impact factor: 5.191

4.  Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.

Authors:  Colin T Shearn; David J Orlicky; Dennis R Petersen
Journal:  Exp Mol Pathol       Date:  2017-11-24       Impact factor: 3.362

Review 5.  Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

Authors:  Koji Miyanishi; Toshifumi Hoki; Shingo Tanaka; Junji Kato
Journal:  World J Hepatol       Date:  2015-03-27

6.  Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats.

Authors:  Hayrettin Ozturk; Halil Eken; Hulya Ozturk; Huseyin Buyukbayram
Journal:  Pediatr Surg Int       Date:  2006-08-01       Impact factor: 1.827

7.  Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.

Authors:  C M Rodrigues; G Fan; P Y Wong; B T Kren; C J Steer
Journal:  Mol Med       Date:  1998-03       Impact factor: 6.354

8.  Ursodeoxycholic acid and superoxide anion.

Authors:  Predrag Ljubuncic; Omar Abu-Salach; Arieh Bomzon
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

Review 9.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.

Authors:  M Aviram; B Fuhrman
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines.

Authors:  Zheng Wu; Yi Lü; Bo Wang; Chang Liu; Zuo-Ren Wang
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.